Sodium-glucose cotransporter 2 inhibitors in real-life patients at high cardiovascular risk

被引：0
|
作者：
Cesaro, Arturo [1 ,2 ]
Fimiani, Fabio [1 ,2 ]
Gragnano, Felice [1 ,2 ]
Moscarella, Elisabetta [1 ,2 ]
Signore, Giovanni [1 ,2 ]
Maratea, Anna Chiara [1 ,2 ]
Rotolo, Francesco Paolo [1 ,2 ]
Vergara, Andrea [1 ,2 ]
Schiavo, Alessandra [1 ,2 ]
Calabro, Paolo [1 ,2 ]
机构：
[1] Univ Campania L Vanvitelli, Dept Translat Med Sci, Naples, Italy
[2] Aorn S Anna E S Sebastiano, Div Cardiol, Caserta, Italy
来源：
EUROPEAN HEART JOURNAL SUPPLEMENTS | 2021年 / 23卷 / SUPPL G期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
785
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Sodium-glucose cotransporter 2 inhibitors and the risk of Parkinson disease in real-world patients with type 2 diabetes
    Guo, Jingchuan
    Tang, Huilin
    Shao, Hui
    Lu, Ying
    Shi, Lizheng
    Fonseca, Vivian A.
    Cho, Hwayoung
    Guo, Yi
    Bian, Jiang
    DIABETES OBESITY & METABOLISM, 2024, 26 (12): : 5727 - 5736
  • [22] Sodium-glucose cotransporter-2 inhibitors reduce the risk of gout
    Pavlicek, Vojtech
    DIABETOLOGE, 2020, 16 (02): : 190 - 191
  • [23] Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Pneumonia and Septic Shock
    Li, Hang-Long
    Tse, Yi-Kei
    Chandramouli, Chanchal
    Hon, Nicole Wing-Lam
    Cheung, Ching-Lung
    Lam, Lok-Yee
    Wu, Meizhen
    Huang, Jia-Yi
    Yu, Si-Yeung
    Leung, Ka-Lam
    Fei, Yue
    Feng, Qi
    Ren, Qingwen
    Cheung, Bernard M. Y.
    Tse, Hung-Fat
    Verma, Subodh
    Lam, Carolyn S. P.
    Yiu, Kai-Hang
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (12): : 3442 - 3451
  • [24] Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Nephrolithiasis in Clinical Practice
    Hsiao, Po-Ren
    Wei, James Cheng-Chung
    JAMA INTERNAL MEDICINE, 2024, 184 (07)
  • [25] Sodium-glucose cotransporter-2 inhibitors reduce risk of nephrolithiasis
    Di Lellis, Maddalena Angela
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2024, 149 (12) : 674 - 675
  • [26] Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Fractures Among Patients With Type 2 Diabetes
    Abrahami, Devin
    Douros, Antonios
    Yin, Hui
    Yu, Oriana H. Y.
    Azoulay, Laurent
    DIABETES CARE, 2019, 42 (09) : E150 - E152
  • [27] Cardiovascular effects of sodium-glucose cotransporter 2 inhibitors: multiple actions Response
    Hansen, Andrew
    Zhang, Jian
    Pritchard, Tony
    Melnic, Irina
    CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (09) : 1517 - 1517
  • [28] Sodium-glucose cotransporter-2 inhibitors in cardiovascular disease: a gaseous solution
    Durante, William
    MEDICAL GAS RESEARCH, 2025, 15 (02): : 206 - 207
  • [29] Cardiovascular and Renal Benefit of Sodium-Glucose Cotransporter Type 2 Inhibitors in Patients With Type 2 Diabetes
    Lam, Steven Ho Man
    Alam, Uazman
    Lip, Gregory Yoke Hong
    AMERICAN JOURNAL OF CARDIOLOGY, 2024, 223 : 183 - 185
  • [30] Sodium-Glucose Cotransporter 2 Inhibitors and Anemia Among Diabetic Patients in Real Clinical Practice
    Murashima, Miho
    Ide, Atsuki
    Ono, Minamo
    Mizuno, Masashi
    Suzuki, Taisei
    Hamano, Takayuki
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 190 - 191
12345